New Report Highlights Risks of U.S. Drug Reimportation

September 6, 2019

New Report Highlights Risks of U.S. Drug Reimportation

While the reimportation of drugs into the U.S. from abroad is a popular topic among politicians and advocates looking for ways to reduce domestic healthcare costs, the research arm of the Healthcare Distribution Alliance has released a new report highlighting some little-discussed costs and risks associated with reimportation. Yourway is no stranger to logistical challenges and is monitoring this issue.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply Europe

February 24-26, 2026
Hyatt Regency, Barcelona Tower

Schedule a Meeting

Global Clinical Supplies Group Asia Pacific Conference

March 10-12, 2026
Conrad Seoul Hotel, South Korea

Schedule a Meeting

Media

Articles

Why Integration Matters in Clinical Supply Chains

Open chat

Hello! How can I help you?